Skip to main content Back to Top
Advertisement

7/12/2019

Ampicillin Sodium and Sulbactam Sodium Injection

Products Affected - Description

    • Unasyn powder for solution for injection, Pfizer, 1.5 gram, vial, 10 count, NDC 00049-0013-83
    • Unasyn powder for solution for injection, Pfizer, 15 gram, bulk vial, 1 count, NDC 00049-0024-28
    • Unasyn powder for solution for injection, Pfizer, 3 gram, vial, 10 count, NDC 00049-0014-83
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, AuroMedics, 1.5 gram, vial, 10 count, NDC 55150-0116-20
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, AuroMedics, 15 gram, bulk vial, 1 count, NDC 55150-0118-99
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, AuroMedics, 3 gram, vial, 10 count, NDC 55150-0117-20
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Fresenius Kabi, 1.5 gram, vial, 10 count, NDC 63323-0368-20
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Fresenius Kabi, 15 gram, bulk vial, 1 count, NDC 63323-0370-62
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Fresenius Kabi, 3 gram, vial, 10 count, NDC 63323-0369-20
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Hikma, 1.5 gram, vial, 10 count, NDC 00641-6116-10
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Hikma, 15 gram, bulk vial, 1 count, NDC 00641-6118-01
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Hikma, 3 gram, vial, 10 count, NDC 00641-6117-10
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Pfizer, 1.5 gram, ADD-Vantage vial, 10 count, NDC 00409-2689-01
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Pfizer, 3 gram, ADD-Vantage vial, 10 count, NDC 00409-2987-03
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Sagent, 1.5 gram, vial, 10 count, NDC 25021-0142-20
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Sagent, 15 gram, bulk vial, 1 count, NDC 25021-0144-99
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Sagent, 3 gram, vial, 10 count, NDC 25021-0143-30
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Sandoz, 1.5 gram, vial, 10 count, NDC 00781-3032-95
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Sandoz, 15 gram, bulk vial, 1 count, NDC 00781-3034-46
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, Sandoz, 3 gram, vial, 10 count, NDC 00781-3033-95
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, WG Critical Care, 15 gram, bulk vial, 1 count, NDC 44567-0212-01

Reason for the Shortage

    • AuroMedics has ampicillin sulbactam vials on back order due to increased demand and manufacturing delays.
    • Pfizer has discontinued generic ampicillin sulbactam except for the 1.5 gram and 3 gram ADD-Vantage vials.
    • Sagent has ampicillin sulbactam vials on back order due to manufacturing delays and increased demand.
    • Sandoz cannot provide a reason for the shortage.
    • WG Critical Care states the shortage is due to increased demand.
    • Mylan Institutional refuses to provide availability information

Available Products

    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, WG Critical Care, 1.5 gram, vial, 10 count, NDC 44567-0210-10
    • Ampicillin Sodium and Sulbactam Sodium powder for solution for injection, WG Critical Care, 3 gram, vial, 10 count, NDC 44567-0211-10

Estimated Resupply Dates

    • AuroMedics has ampicillin sulbactam 3 gram and 15 gram vials on intermittent back order and the company is releasing product as it becomes available. The 1.5 gram vials are on long-term back order and the company cannot estimate a release date.
    • Fresenius Kabi has ampicillin sulbactam 1.5 gram, 3 gram, and 15 gram vials on long-term back order and the company cannot estimate a release date.
    • Hikma has ampicillin sulbactam 1.5 gram, 3 gram, and 15 gram vials on back order and the company estimates a release date of early-November 2019.
    • Pfizer has Unasyn 1.5 gram, 3 gram, and 15 gram bulk vials are on back order and the company estimates a release date of September 2019. The 1.5 gram and 3 gram ADD-Vantage vials are on back order and the company estimates a release date of October 2019 for the 1.5 gram vials and September 2019 for the 3 gram vials.
    • Sandoz has ampicillin sulbactam 1.5 gram, 3 gram, and 15 gram vials on long-term back order and the company cannot estimate a release date.
    • Sagent has ampicillin sulbactam 1.5 gram vials, 3 gram vials, and 15 gram bulk vials on back order and the company cannot estimate a release date.
    • WG Critical Care has ampicillin sulbactam 15 gram vials on back order and the company cannot estimate a release date.

Updated

Updated July 12, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 24, 2011 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins